Fulminant hepatitis caused by hepatitis C virus during treatment for multiple sclerosis
β Scribed by Masato Funaoka; Kazumaro Kato; Masafumi Komatsu; Tsuyoshi Ono; Takao Hoshino; Junji Kato; Tomoyuki Kuramitsu; Tohru Ishii; Itaru Toyoshima; Osamu Masamune
- Book ID
- 105119843
- Publisher
- Springer Japan
- Year
- 1996
- Tongue
- English
- Weight
- 636 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis C virus (HCV) RNA decay during antiviral therapy is characterized by a rapid first phase, followed by a slower second phase. The current understanding of viral kinetics attributes the magnitude of the first phase of decay to treatment effectiveness, whereas the second phase of decay is att
A panel of 16 type-specific synthetic peptides corresponding to variable antigenic regions within the hepatitis C virus (HCV) core, nonstruc-tural4 (NS4), and NS5 proteins was synthesised. The peptide panel was used to develop an enzyme immunoassay (EIA) for the detection of antibodies directed to H